ROSEN, A WELL-KNOWN LAW FIRM, Promotes Applied Therapeutics, Inc. Consumers Protect Advice Ahead of Critical Deadline in Securities Class Action

0 0 2 minutes read

ROSEN, A WELL-KNOWN LAW FIRM, Promotes Applied Therapeutics, Inc. Consumers Protect Advice Ahead of Critical Deadline in Securities Class Action

New York, New York–(Newsfile Corp. – December 21, 2024) – WHY: The Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: NASDAQ:) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to act as the lead plaintiff, you must remove the Court early February 18, 2025.

Now: If you purchased securities of Applied Therapeutics during the Class Period you may be entitled to compensation without payment of any out-of-pocket payments or expenses through a contingency fee arrangement.

What you need to do next: To join an Applied Therapeutics class action, visit or call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for information about the class action. A class action lawsuit has already been filed. If you wish to act as a lead plaintiff, you must remove the Court no later than February 18, 2025. The lead plaintiff is the organization representing the other members of the class directing the lawsuit.

Why Rosen Law: We encourage investors to choose qualified advisors with a track record of success in leadership roles. Generally, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in choosing advice. The Rosen Law Firm represents investors worldwide, focusing its practice on securities class actions and shareholder exit litigation. The Rosen Law Firm won the largest securities class action settlement ever against a Chinese Company at the time. The Rosen Law Firm is ranked #1 by ISS Securities Class Action (WA:) Value services for securities class agreements in 2017. The company has been listed in the top 4 every year since 2013 and has returned hundreds of millions of dollars to investors. In 2019 alone the company secured more than 438 million from investors. In 2020, founding partner Laurence Rosen was named by Law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s lawyers are recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, the statements made during the class were false and/or grossly misleading because they concealed and distorted Applied Therapeutics’ existing protocols and procedures. Therefore, the defendants gave investors a false impression that the protocol and good clinical practices were properly followed. The case alleges that, in fact, Applied Therapeutics did not adhere to the trial protocol and good clinical practices, which, in turn, created a serious risk that the trial data would be rejected by the FDA in the context of New Drug Use. When true information enters the market, the lawsuit claims that investors suffered damages.

To join the Applied Therapeutics class action, go call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for information about the class action.

No Class Guaranteed. Until the class is certified, you are not represented by an attorney unless you retain it. You can choose the advice of your choice. You can also remain a member of the missing class and do nothing for now. The investor’s ability to participate in any potential future returns is not dependent on performance as the lead claimant.

Advocate advertising. Previous results do not guarantee the same result.

——————————

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/234795

Source link